Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Image

Povorcitinib for nonsegmental vitiligo: two randomized, controlled, phase 3 STOP-V trials

Journal content Created on 02 Nov 2026 Nature Medicine

Published in

Nature Medicine, Nature Publishing Group

Content

There is no additional content. Please click on the source link to view more information.

Amit G. Pandya

Advertisement

Stats

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 19
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement